Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily J Cox

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Drugs in R&D|November 8, 2023
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use DisorderJames C Miller, Michael A Brooks, Kelly E Wurzel, et al.
Journal of Addiction Medicine|February 15, 2022
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/NaloxoneHazel D Brogdon, Mackenzie M McPhee, Mary F Paine, et al.
Clinical and Translational Science|October 26, 2021
Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approachEmily J Cox, Allan E Rettie, Jashvant D Unadkat, et al.
Plos One|June 30, 2022
Patient experience and healthcare utilization for a COVID-19 telemedicine home monitoring program offered in English and SpanishKeri B Vartanian, Megan Holtorf, Emily J Cox, et al.
Pharmacology & Therapeutics|May 10, 2019
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokineticsEmily J Cox, Neha Maharao, Gabriela Patilea-Vrana, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 28, 2019
Indinavir Increases Midazolam <i>N</i>-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo ApproachDan-Dan Tian, Cathrine Leonowens, Emily J Cox, et al.
Pharmacological Reviews|March 13, 2021
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended ApproachEmily J Cox, Dan-Dan Tian, John D Clarke, et al.
The Ultrasound Journal|September 6, 2021
Comparing accuracy of bedside ultrasound examination with physical examination for detection of pleural effusionMichael H Walsh, Kang X Zhang, Emily J Cox, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|April 2, 2021
Integration of Point-of-Care Ultrasound Education Into the Internal Medicine Core Clerkship ExperienceJason E Lambrecht, Kang Zhang, David M Tierney, et al.
The Journal of Invasive Cardiology|May 20, 2022
Comparison of 26-mm Evolut and 23-mm Sapien 3 Valves in TAVR for Small Aortic AnnulusRuyun Jin, Emily J Cox, Branden R Reynolds, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Drugs in R&D|November 8, 2023
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use DisorderJames C Miller, Michael A Brooks, Kelly E Wurzel, et al.
Journal of Addiction Medicine|February 15, 2022
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/NaloxoneHazel D Brogdon, Mackenzie M McPhee, Mary F Paine, et al.
Clinical and Translational Science|October 26, 2021
Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approachEmily J Cox, Allan E Rettie, Jashvant D Unadkat, et al.
Plos One|June 30, 2022
Patient experience and healthcare utilization for a COVID-19 telemedicine home monitoring program offered in English and SpanishKeri B Vartanian, Megan Holtorf, Emily J Cox, et al.
Pharmacology & Therapeutics|May 10, 2019
A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokineticsEmily J Cox, Neha Maharao, Gabriela Patilea-Vrana, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 28, 2019
Indinavir Increases Midazolam <i>N</i>-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo ApproachDan-Dan Tian, Cathrine Leonowens, Emily J Cox, et al.
Pharmacological Reviews|March 13, 2021
Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended ApproachEmily J Cox, Dan-Dan Tian, John D Clarke, et al.
The Ultrasound Journal|September 6, 2021
Comparing accuracy of bedside ultrasound examination with physical examination for detection of pleural effusionMichael H Walsh, Kang X Zhang, Emily J Cox, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|April 2, 2021
Integration of Point-of-Care Ultrasound Education Into the Internal Medicine Core Clerkship ExperienceJason E Lambrecht, Kang Zhang, David M Tierney, et al.
The Journal of Invasive Cardiology|May 20, 2022
Comparison of 26-mm Evolut and 23-mm Sapien 3 Valves in TAVR for Small Aortic AnnulusRuyun Jin, Emily J Cox, Branden R Reynolds, et al.
Pageof 3